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Abstract.  The identification of a  novel protein from 
Drosophila  melanogaster  that binds both mammalian 
epidermal growth factor (EGF) and insulin has been 
reported (Thompson, K. L., S. J.  Decker, and M.  R. 
Rosner,  1985, Proc. Natl.  Acad.  Sci.  USA., 
82:8443-8447).  This  100-kD protein (designated 
dpl00)  is also recognized by an antiserum against the 
human EGF receptor.  To further characterize the prop- 
erties of this protein,  we have determined the binding 
spectrum, glycosylation state, and cellular distribution 
of dpl00.  Our results indicate that dpl00 binds to other 
insulin-like and EGF-like growth factors with dissocia- 
tion constants ranging from 10  -6 to  10  -9 M, and these 
ligands compete with each other for binding to dpl00. 
All other ligands tested, including platelet-derived 
growth factor, transforming growth factor-beta, nerve 
growth factor, and glucagon, either did not bind or 
bound with a  Kd >10  -6 M.  Unlike the Drosophila  insu- 
lin receptor, dpl00 does not bind to wheat germ agglu- 
tinin and is present in a  cytoplasmic as well as a 
membrane-bound form that cannot be differentiated by 
two-dimensional PAGE.  Further, dpl00 is the sole 
transforming growth factor-alpha-binding protein de- 
tected by affinity labeling in Drosophila  Kc cells. 
These results indicate that dpl00 shares properties in 
common with, but distinct from, the Drosophila 
homologues of the insulin and EGF receptors. 
I 
DENTIFICATION and characterization of homologues of 
mammalian growth regulatory proteins in lower organ- 
isms is an approach that can potentially yield new and 
relevant insights into the mechanism of action of these pro- 
teins. In vertebrates, growth factors that are members of the 
insulin and epidermal growth factor (EGF) 1 families are in- 
tegrally involved in the stimulation of mitogenesis and con- 
trol of cellular metabolism (20).  Further understanding of 
their biochemical interactions could benefit from identifica- 
tion and investigation of proteins that bind these factors in 
genetically characterized lower organisms. 
In the interests of developing this approach, we screened 
Drosophila melanogaster cell lines for proteins related to the 
EGF receptor using a  polyclonal antisera that recognizes 
EGF receptors from a  variety of species (2)  but does not 
cross react with the mammalian or the Drosophila insulin 
receptor (24).  In the course of this investigation, we iden- 
tified in membrane fractions a  190-kD  protein that corre- 
sponds to the Drosophila EGF receptor homologue and a 
growth factor-binding protein for both insulin and EGF of 
~,100 kD (24).  This latter protein (designated dpl00) is the 
subject of the present paper. 
1.  Abbreviations  used in this paper:  dplO0,  100-kD Drosophila  protein; 
EGE epidermal growth factor; IGE insulin-like growth factor; NGF, nerve 
growth factor;  PDGF,  platelet-derived  growth  factor;  PTH,  parathyroid 
hormone; WGA, wheat germ agglutinin. 
On the basis of the recognition by anti-EGF receptor an- 
tiserum and the affinity labeling with insulin and EGF, we 
proposed that dpl00 was a novel receptor (24) distinct from 
the Drosophila homologues of the EGF (13, 21) and insulin 
receptors (17). To explore this possibility further, we charac- 
terized the binding spectrum, glycosylation state, and cellu- 
lar distribution of dpl00.  The results indicate that (a) dpl00 
specifically  binds  to  all  intact  insulin  and  EGF-related 
growth factors tested, which compete with one another for 
binding; (b) dpl00 does not appear to be N-glycosylated and 
is located primarily in the cytoplasm of the cell;  and (c) 
dpl00 is the only transforming growth factor-alpha (TGF- 
alpha)-binding protein detected by affinity labeling in Dro- 
sophila Kc cells. This new evidence suggests that dpl00 is 
not a receptor, but a discrete binding protein for insulin and 
EGF-related factors. 
Materials and Methods 
Materials. Drosophila Kc cells,  from the Massachusetts Institute of Tech- 
nology Cell Culture Center, were grown in D22 media. Human epidermoid 
carcinoma A431 cells were obtained from the American Type Culture Col- 
lection, Rockville, MD. Anti-EGF receptor antiserum was prepared against 
denatured EGF-R from A431 cells (2). Growth factors were obtained from 
the following sources: murine EGF (receptor grade and HPLC purified) and 
porcine insulin (Biomedical  Technologies,  Inc.,  Cambridge,  MA),  125I- 
TGF-alpha and t25I-TGF-beta (J. Massague),  IGF-I (Amgen), IGF-II (M. 
Czech), synthetic human TGF-alpha  (J. Tam), nerve growth factor (NGF) 
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dpl00 with iodinated insulin-like 
and EGF-like growth factors. Sol- 
ubilized  Drosophila  membrane 
proteins  were  immunoprecipi- 
tated with anti-EGF receptor an- 
tiserum and incubated with  ~2sI- 
labeled growth factors (~10  -8 M) 
in the absence (lanes 1, 3, 5,  7, 9, 
and  //)  or  presence  of  excess 
(2.5-10  ~M) insulin (lanes 4,  8, 
10,  and  12) or EGF (lanes 2  and 
6). Samples were labeled with in- 
sulin (lanes I  and 2), IGF-I (lanes 
3  and 4),  EGF  (lanes 5  and 6), 
TGF-alpha (lanes 7and 8), PDGF 
(lanes  9  and  10),  and TGF-beta 
(lanes //  and 12).  Proteins were 
cross-linked and analyzed by au- 
toradiography  as  described  in 
Materials and Methods. The lower 
band that is not competed by un- 
labeled insulin is BSA. 
(G. Johnson), 125I-platelet-derived  growth factor (PDGF) (J. Votano and H. 
Antoniades),  parathyroid hormone (PTH),  insulin A  and B chains, and 
glucagon  (Sigma  Chemical Co.,  St.  Louis,  MO),  and human urokinase 
amino terminal fragment (E Blasi).  125I-EGF  was prepared by the chlora- 
mine T  method, while insulin and TGF-alpha  were  iodinated  using En- 
zymobeads (BioRad Laboratories,  Cambridge, MA). The specific activities 
were  ,,o50-150 IxCi/l~g. Markers for isoelectric  focusing  and SDS-PAGE 
were purchased from Sigma Chemical Co. Wheat germ agglutinin (WGA)- 
Sepharose was purchased from Sigma Chemical Co. Ampholites were from 
LKB Instruments, Inc., Gaithersburg,  MD. 
Membrane Preparation.  Drosophila cells were harvested  from suspen- 
sion cultures by centrifugation.  Cells were washed twice in PBS and once 
in buffer A (20 mM Tris-HCl pH 7.5, 150 mM NaCI,  1 mM EDTA,  1 mM 
EGTA, 1 mM phenylmethylsnlfonyl  fluoride, 0.25 TIU/ml aprotinin, 5 I~M 
leupeptin, 25 mM benzamidine). The cells were then swollen in buffer A 
without NaC1 and lysed  in a  Dounce homogenizer (Kontes  Glass Co., 
Vineland, NJ). The lysates were cleared by low speed centrifugation and 
then subjected to centrifugation  at 100,000  g. The supernatant (cytoplasmic) 
fraction was stored at -70°C. The membrane fraction was resuspended in 
buffer A, subjected to centrifugation a second time, and the resultant pellet 
resuspended in 50 mM Hepes pH 7.4, and stored at -70°C. Membrane pro- 
tein concentration was determined by the method of Bradford  (1). 
A~inity Labeling  oflmraunoprecipitates.  Membrane protein was solu- 
bilized in buffer containing Triton X-100 and immunoprecipitated  as previ- 
ously described (24).  l~I-insulin or another radiolabeled ligand was added 
at 2-20 nM and the samples were incubated for 60 min at 15°C. In competi- 
tive binding assays, unlabeled and labeled ligands  were added simultane- 
ously at 4°C. Bound growth factor was cross-linked  to receptor proteins by 
addition of disuceinimidyl  suberate and subjected to electrophoresis as pre- 
viously described (24).  In the competitive  binding studies,  the extent  of 
t25I-insulin  binding to the 100-kD protein was quantitated  by scanning that 
region of the gel with a microdensitometer (LKB Instruments, Inc.) linked 
up to an integrator (Hewlett-Packard  Co., Palo Alto, CA). To ensure linear- 
ity, several exposures  were taken.  Dissociation constants were determined 
by statistical  analysis  with a computer program developed  by M. Bolger 
(Labsoft  Solutions,  Los  Alamitos,  CA)  using a  single-site  competition 
model. For direct affinity labeling, cytoplasmic or membrane proteins were 
cross-linked  as above with labeled ligand except that the immunoprecipita- 
tion and washing  steps were omitted. 
Growth Factor Binding to .4431 cells. A431 cells were grown in mono- 
layer and mI-labeled EGF bound to the cells as previously  described (6). 
Chromatography on Wheat Germ Agglutinin  (WGA)-Sepharose.  Chro- 
matography on a WGA-Sepharose column was performed as described for 
the Drosophila  insulin receptor (17). 
Two-Dimensional  PAGE. High resolution two-dimensional  electropho- 
resis of proteins was performed as described by O'Farrell (16). Electropho- 
resis on a tube gel in an ampholine gradient ranging from pH 3.5 to pH 10 
was followed by SDS-PAGE on a 7.5 % acrylamide slab gel. Protein markers 
were used to determine the pI of the resulting spots. 
Results 
In previous work,  a  100-kD protein from Drosophila that 
displayed dual binding specificity for both insulin and EGF 
was identified (24).  This protein (dpl00)  was initially de- 
tected by immunoprecipitation of detergent-solubilized  mem- 
branes with an antiserum prepared against the human EGF 
receptor (2)  and subsequent cross-linking with 125I-labeled 
insulin or EGE dpl00 was found in membrane fractions from 
two different  Drosophila cell lines. An excess of either unla- 
beled  insulin  or  EGF  could  block  binding  of both  ~25I- 
labeled insulin or EGF to dpl00.  To further characterize the 
properties  of  this  protein,  we  determined  the  binding 
specificity,  glycosylation state, and cellular distribution of 
dpl00. 
To test whether the binding specificity of dpl00 extended 
to other growth factors structurally similar to insulin and 
EGF (9,  14,  19), we performed immunoprecipitation and 
affinity labeling with the  125I-labeled ligands (see Fig.  1). 
The results indicate that dpl00 could be affinity labeled with 
all the insulin-like and EGF-like growth factors tested (TGF- 
alpha,  EGF,  insulin,  and  IGF-I),  and  that  radiolabeled 
growth factor binding could be inhibited in all cases by addi- 
tion of excess unlabeled insulin or the specific ligand (Fig. 
1).  However,  neither  125I-TGF-beta nor  125I-PDGF, two 
structurally unrelated growth factors (3,  4,  27),  could be 
cross-linked to dpl00 or any other immunoprecipitated Dro- 
sophila protein under the conditions of  our experiment. Con- 
trois  with preimmune serum  failed to  immunoprecipitate 
dpl00 or any other growth factor-binding protein (data not 
shown). 
Having identified other EGF-like and insulin-like factors 
that can be cross-linked to dpl00, we determined the relative 
binding affinities  of  these and other hormones by competitive 
affinity-labeling  experiments. For these experiments, solubi- 
lized  Kc  cell  membranes  were  immunoprecipitated with 
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dpl00  with  ~25I-insulin in the 
presence of unlabeled growth 
factors. Drosophila  membrane 
immunoprecipitates were cross- 
linked with labeled insulin as 
described in Fig. 1 in the pres- 
ence of (A) TGF-alpha (lane 1, 
1.2  ~tM; lanes  2  and  3,  0.12 
~tM; lanes 4 and 5, 0.012 ~tM; 
lanes 6and 7, 1.2 nM; lanes 8 
and 9, 0.12 nM;  lanes 10 and 
11, no addition), or (B) insulin 
(lane  1,  55  txM; lane  2,  5.5 
~tM; lane 3, 0.55 ~tM; lane 4, 
0.055  ~tM; lane  5,  5.5  nM; 
lane 6, no addition),  or EGF 
(lane 7, 1 laM; lane 8, 0.1 labt; 
lane 9, 0.01 txM; lane 10, 1 nM; 
lane  //,  0.1  nM;  lane  12,  no 
addition). 
anti-EGF receptor antibody, and the immunoprecipitate was 
affinity labeled with t25I-insulin in the presence of different 
concentrations of unlabeled ligand.  The samples were then 
cross-linked before gel electrophoresis and autoradiography. 
Autoradiograms  illustrating  the  competition by unlabeled 
TGF-alpha, insulin, and EGF are shown in Fig. 2. The com- 
petitive binding curves (Fig. 3), derived from densitometric 
scanning of the autoradiograms, were used to calculate the 
relative binding affinities (Table I), Synthetic human-trans- 
forming growth  factor-alpha (TGF-alpha) and  insulin-like 
growth  factor-II (IGF-II) bound  with the  highest affinities 
(Kd of 5  X  10  -9 M  and  1.3  x  10  -s M,  respectively). EGF, 
insulin, and insulin-like growth factor-I (IGF-I) bound with 
dissociation constants  ranging from  10  -6 to  10  -7 M  (Table 
I). Nerve growth factor (NGF) and glucagon (Fig. 3) as well 
as pituitary thyroid hormone (PTH) (data not shown) showed 
some ability to compete but the dissociation constants were 
higher than  10-6 M.  No significant binding was detected to 
the individual A and B chains of insulin at concentrations up 
to  10  -5 M  (data not shown),  similar to results obtained for 
the  mammalian insulin  receptor  (5).  The  amino-terminal 
fragment of urokinase, which binds to the urokinase receptor 
with an affinity comparable to that of the native enzyme and 
has cysteine residues spaced similarly to those in EGF (23), 
did not compete with 125I-insulin at concentrations up to 3 
x  10  -4 M  (data not shown).  It should be noted that all the 
ligands tested were from mammalian sources and thus are 
not the endogenous ligands for dpl00.  The affinity of dpl00 
for TGF-alpha and IGF-II is as high as that reported for the 
binding of porcine insulin to the Drosophila insulin receptor 
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Figure 3.  Competitive binding of labeled insulin to dpl00 in the 
presence of insulin-like and EGF-like growth factors. Drosophila 
membrane immunoprecipitates were cross-linked with labeled in- 
sulin as described in Fig. 1 in the presence of unlabeled growth fac- 
tors. Autoradiograms (see Fig. 2 and Materials and Methods) were 
scanned and the relative amount of labeled dpl00 quantitated. Insu- 
lin binding is expressed as percent of controls containing no com- 
petitor ligand (100%). 
(17). These results indicate that dpl00 binds to mammalian 
insulin-like and EGF-like growth factors with a high affinity 
and specificity for a heterologous system. 
dpl00  bound  to  synthetic  human  TGF-alpha  with  an 
affinity three orders of magnitude higher than that for EGF 
and has the unique ability to bind and differentiate between 
these two ligands. To ensure that the difference in the binding 
affinities of EGF and TGF-alpha for dpl00 reflected a prop- 
erty of the protein rather than the particular growth factor 
preparations, we determined the ability of unlabeled EGF 
and TGF-alpha to compete with IZ~I-labeled EGF for bind- 
ing to the EGF receptor in human epithelial carcinoma A431 
cells. As shown in Fig. 4, there was no significant difference 
in the affinities of the EGF and TGF-alpha preparations for 
Table I. Dissociation Constants  for Ligand Binding to dp I O0 
Ligand  Kd (n)* 
TGF-alpha 
EGF 
Insulin 
IGF-I 
IGF-II 
Glucagon 
NGF 
PTH 
Insulin A  chain 
Insulin B  chain 
5  X  10  .9 (4) 
1.3  X  10  -6  (4) 
1.1  X  10  -7  (4) 
5  X  10  -7  (2) 
1.3  X  10  -s (2) 
>10 -6 
>10  -6 
>10  -6 
>10 -6 
>10 -6 
* (n)  =  number of determinations. 
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Figure 4. Competitive binding of murine EGF and synthetic human 
TGF-alpha to the EGF receptor in A431 cells. 125I-EGF (105 cpm) 
was incubated with A431 cells (2 x  104/well)  at 4°C for 3 h in the 
presence of different concentrations of unlabeled EGF (o) or TGF- 
alpha (o). The data are the mean of duplicate determinations and 
the error was within 10%. 
the mammalian EGF receptor. The data presented here sug- 
gests that dpl00 recognizes EGF and TGF-alpha in a different 
way than the EGF receptor. The fact that dpl00 and the mam- 
malian EGF receptor are both able to bind to EGF and TGF- 
alpha suggests that there might be some common recognition 
sites in their binding domains. However, specific recognition 
sites of dpl00 and the EGF receptor must differ because only 
dpl00 can differentiate between the two growth factors. 
Since the mammalian receptors for EGF and insulin are 
glycosylated (10, 22), we determined whether the Drosophila 
dpl00  might  also  contain  asparagine-linked  oligosaccha- 
rides.  To test for the presence of oligosaccharides,  mem- 
brane  fractions  from  Kc  cells  were  applied  to  a  WGA- 
Sepharose column. This latter column, which binds to N-ace- 
tylglucosamine residues, has been shown to retain both the 
mammalian and Drosophila insulin receptors (10, 17). After 
application of Triton-solubilized Kc cell membrane fractions 
to the WGA-Sepharose column, the flowthru was collected, 
the column washed,  and the retained proteins specifically 
eluted with N-acetylglucosamine. To identify insulin-bind- 
ing proteins, samples from the flowthru and the eluant were 
either immunoprecipitated and labeled, or labeled directly, 
with 125I-insulin. Labeled proteins were then visualized by 
autoradiography after SDS-PAGE. As shown in Fig. 5, sam- 
pies that bound insulin and were in the molecular mass range 
of 100-130 kD were detected in both the flowthru and eluted 
fractions. However, when dpl00 was selectively visualized 
by prior precipitation with the anti-EGF receptor antiserum 
and affinity labeling with  125I-insulin, dpl00 was  only de- 
tected in  samples  from the flowthru.  Direct cross-linking 
with 125I-TGF-alpha  was more specific and only labeled pro- 
teins  in  the  flowthru,  but  not  the  eluate,  of the  WGA- 
Sepharose column (Fig.  5).  A  similar elution pattern  for 
dpl00  was  obtained  when  a  lentil  lectin  column,  which 
recognizes mannose and glucose residues, was used (data not 
shown). Similarly, treatment of dpl00 with endoglycosidase 
H, which cleaves N-asparagine-linked high mannose oligo- 
saccharides, did not result in an electrophoretically  detectable 
loss of oligosaccharide chains under conditions that caused 
a shift in the electrophoretic mobility of ovalbumin (data not 
shown). These results indicate that dpl00 can be separated 
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fractions  from the  WGA-Sepharose 
column. Solub'flized  membranes were 
loaded to a WGA-Sepharose column 
(0.3 ml). Aliquots from the load (L), 
flowthru (FT),  and eluant (E) were 
assayed  for the  presence  of dpl00. 
Samples  in lanes  1-3  were  labeled 
with  t25I-insulin after  immunopre- 
cipitation  with  anti-EGF  receptor 
antisera.  Samples in lanes 4-9 were 
labeled  directly  with  125I-insulin in 
the presence (4, 6, and 8) or absence 
(5,  7, and 9) of excess unlabeled in- 
sulin. Lanes 10-15 show samples la- 
beled with L~I-TGF-alpha  in the pres- 
ence (11, 13, and 15) or absence  (10, 
12, and 14) of excess unlabeled insu- 
lin.  Samples were cross-linked  and 
analyzed by electrophoresis followed 
by autoradiograpby  as described  in 
Materials  and  Methods.  The lower 
band  that is not competed by unla- 
beled ligand is BSA. 
Figure 6. Distribution ofdpl00 in 
Drosophila Kc cells. (A) Samples 
from solubilized membranes and 
cytoplasm were  immunoprecipi- 
tated with anti-EGF receptor an- 
tisera.  Immunoprecipitates  were 
labeled  with  u5I-insulin  in  the 
presence or absence of unlabeled 
insulin  or EGF. (B) Samples  of 
solubilized membrane (2 mg) and 
cytoplasmic (4.5 mg) protein were 
immunoprecipitated with 6 (lanes 
I and 4), 12 (lanes 2 and 5), and 
18 ~tl (lanes 3 and 6) of anti-EGF 
receptor  antisera.  Samples  were 
cross-linked,  and  analyzed  by 
electrophoresis followed by auto- 
radiography as described  in Ma- 
terials and Methods. 
from the insulin receptor by lectin chromatography and sug- 
gest that membrane-associated dpl00 is not glycosylated. 
The previous studies were conducted with membrane frac- 
tions, consistent with a putative role for dpl00 as a growth 
factor receptor. However, to gain more perspective on the na- 
ture of the protein, we examined the cellular distribution of 
dpl00. Initially, dpl00 was identified by immunoprecipitation 
with the anti-EGF receptor antiserum and subsequent cross- 
linking with t25I-labeled  insulin in the presence or absence 
of unlabeled insulin or EGF. When cytoplasmic and mem- 
brane fractions were analyzed by this method, dpl00 was de- 
tected in both fractions (Fig. 6 A) and, in fact, was found pre- 
dominantly  in  the  cytoplasmic  fraction  when  saturating 
levels of the antiserum were used (Fig. 6 B). Despite exten- 
sive washing with PBS,  a  fraction of the dpl00 (~5%) re- 
mained membrane associated (data not shown). When intact 
Kc cells were assayed for binding or cross-linking to radiola- 
beled insulin or TGF-alpha, minimal binding was detected 
under conditions where equivalent amounts of the isolated 
Kc membranes were extensively labeled (data not shown). 
These results are consistent with the majority of the dpl00 
being on the inside of the cell in both membrane-associated 
and cytoplasmic forms. Thus dpl00 is not a direct counter- 
part of the mammalian growth factor receptors that are lo- 
cated in membrane-associated fractions and have their bind- 
ing domains exposed on the extracellular surface. 
To  determine  whether  the  cytoplasmic  and  membrane 
forms of dpl00 differed in  any significant respect,  several 
criteria were used. The cytoplasmic dpl00 was identified on 
the basis of molecular weight, recognition by the anti-EGF 
Garcia et al. Insulin and EGF Binding Protein from Drosophila  453 Figure 7. Autoradiograph depicting two-dimensional PAGE  of 125I-insulin-labeled  dpl00. Kc cell cytoplasmic fractions (A and B) or mem- 
brane fractions (C and D) were immunoprecipitated with anti-EGF receptor antibody and the immunoprecipitates affinity labeled with 
125I-insulin in the presence (B and D) or absence (A and C) of unlabeled insulin. The arrows indicate the spots corresponding to affinity- 
labeled dpl00. 
receptor antiserum, and ability to bind to insulin, EGF, and 
TGF-alpha. To further test the identity of the cytoplasmic and 
membrane-associated forms of dpl00,  we compared their 
chromatographic mobility after two-dimensional gel elec- 
trophoresis (Fig. 7). Cytoplasmic and membrane extracts of 
Kc cells were immunoprecipitated with anti-EGF receptor 
antibody and then cross-linked with ~25I-labeled insulin be- 
fore separation by isoelectric focusing and SDS-PAGE. The 
results  show  identical  profiles  for  both  cytoplasmic  and 
membrane samples. The fact that two proteins correspond- 
ing to dpl00 that differ in pI (pIi ,06; pI2 "~7) are observed 
may reflect two different proteins, two forms of  the same pro- 
tein, or may be an artifact of the ligand-cross-linking pro- 
cess. These results indicate that the cytoplasmic and mem- 
brane-associated forms of dpl00 are similar, if not identical. 
Since dpl00  appeared to be most specific for synthetic 
TGF-alpha, we determined whether there are any other TGF- 
alpha-binding proteins in either the cytoplasmic or mem- 
brane-associated  fractions.  When  samples  that  had  been 
directly affinity labeled with 125I-TGF  alpha were compared 
with  samples  that  had  been immunoprecipitated with the 
anti-EGF receptor antibody before affinity labeling, no dif- 
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alpha. Cytoplasmic proteins were labeled with TGF-alpha directly 
(lanes 4-6) or after immunoprecipitation with anti-EGF receptor 
antisera (lanes 1-3). Samples were labeled in presence or absence 
of excess insulin or EGF. After cross-linking, samples were ana- 
lyzed by electrophoresis followed by autoradiography as described 
in Materials and Methods. The positions of molecular mass mark- 
ers in kilodaltons are indicated. 
ference was detected (see Fig.  5  for membrane fractions, 
Fig.  8 for cytoplasmic fractions). These results indicate that, 
within the limits of our detection system, dpl00 is the only 
TGF-alpha-binding protein in Drosophila Kc cells and, un- 
like insulin, TGF-alpha can be used as a specific probe for 
the protein. 
Discussion 
Previous studies have identified a  100-kD  protein in Dro- 
sophila (dpl00) that is recognized by an anti-EGF receptor 
antisera and binds both mammalian insulin and EGE  We 
have now demonstrated that dpl00 recognizes not only insu- 
lin and EGF but also insulin-like and EGF-like growth fac- 
tors with dissociation constants  ranging from 10  -6 to  10  -9 
M.  In contrast, hormones and growth factors that are not 
members of these families do not bind or bind with dissocia- 
tion constants  that are  >10  -6 M.  Further,  the  insulin  and 
EGF-like factors compete with one another for binding to 
dpl00. These results indicate that insulin-like and EGF-like 
growth  factors can  bind  with  high  specificity to  a  single 
protein. 
Although mammalian ligands were used to probe the bind- 
ing specificity of a Drosophila protein, we were able to mea- 
sure dissociation constants that fall within the mammalian 
physiological range. The binding affinity of IGF-II for dpl00 
is comparable to that reported for the binding of mammalian 
insulin to the Drosophila insulin receptor (17). However, we 
cannot rule out the possibility that a corresponding Drosoph- 
ila ligand may bind with higher affinity.  Although no Dro- 
sophila homologues of mammalian EGF or TGF-alpha have 
been identified to date,  an insulin-like molecule has been 
found in Drosophila (12, 15). Other potential Drosophila 
counterparts of mammalian growth factor receptors are the 
decapentaplegic gene (7), which is homologous to TGF-beta, 
and the Notch gene (8,  11, 26), which has cysteine repeats 
similar to those in EGE It is also possible that other hor- 
mones, either of mammalian or Drosophila origin that are 
not members Of the insulin and EGF families, might also be 
found to bind dpl00. 
The results presented here clearly establish that the protein 
recognized by the anti-EGF receptor antisera, dpl00, is not 
the alpha subunit of the Drosophila insulin receptor. Like the 
mammalian counterpart, the adult Drosophila insulin recep- 
tor is composed of two insulin binding alpha subunits of 130 
kD and two beta subunits of 90 kD that contain the tyrosine 
kinase domain (17). An embryonal insulin binding subunit of 
110 kD has also been reported (18). Both forms of the insulin 
receptor alpha subunit have been shown to bind to WGA. As 
illustrated in Fig. 5, we have demonstrated that Drosophila 
Kc cells also contain an insulin-binding ll0-kD protein that 
is retained by WGA. However, only the insulin-binding pro- 
teins that do not bind to the lectin column are cross-reactive 
with the anti-EGF receptor antisera. This observation, and 
the fact that the mammalian insulin receptor is exclusively 
membrane  bound  whereas  dpl00  is  also  present  in  the 
cytoplasm, argues that they are distinct proteins. 
dpl00  can  be  differentiated from the  Drosophila  EGF 
receptor homologue on the  basis  of molecular mass  and 
binding spectrum. Using the same anti-EGF receptor anti- 
sera, we have identified a  190-kD protein from Drosophila 
cells (24) that corresponds to the expected size of the Dro- 
sophila c-erbB product (21). Despite the antigenic relation- 
ship to the mammalian EGF receptor, the  190-kD  protein 
could not be detected by affinity labeling with either labeled 
EGF  or  TGF-alpha.  Since no  endogenous ligand  corres- 
ponding to EGF or TGF-alpha have yet been identified in 
Drosophila, it is possible that this growth factor is less con- 
served  evolutionarily than  insulin.  However,  mammalian 
EGF is specifically bound by one Drosophila protein, dpl00, 
which is also the only binding protein for TGF-alpha that we 
can detect in these cells. 
The fact that dpl00 recognizes both insulin-like and EGF- 
like growth factor families, and that the conserved sequences 
among  the  growth  factors that  bind  to  dpl00  do  include 
regions of the receptor-binding domains, is consistent with 
the possibility that the binding domains of dpl00 are evolu- 
tionarily related to those of the respective receptors. The pri- 
mary structures of the human insulin receptor and of both 
human and Drosophila EGF receptors have been determined 
(13, 25). Comparison of their extracellular binding domains 
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along  the  protein  molecule.  By  contrast,  the  cysteine 
residues in the binding domain of the PDGF receptor (28) 
are less clustered and resemble those for colony stimulating 
factor-I  receptor.  Thus,  the  receptors  for  EGF-like  and 
insulin-like growth factors  may be more closely related  to 
each other than to other peptide growth factor receptors. 
Receptors are not the only proteins that bind these growth 
factor  families.  Hormone  carrier  proteins  and  hormone 
modifying enzymes have been well characterized  in the liter- 
ature.  The  results  presented  here  demonstrate  that  dpl00 
has certain properties that distinguish  it from mammalian 
growth  factor  receptors.  Further,  no cross-reactivity  with 
other preparations  of anti-EGF receptor antisera  have been 
observed,  suggesting  that  the  recognition  may  be  limited 
to one  particular  anti-EGF  receptor  antiserum  (data  not 
shown). Recent evidence suggests that dpl00 copurifies with 
an insulin degrading activity (Garcia, J. V., M. P. Stoppelli, 
S. J. Decker, and M. R. Rosner,  manuscript in preparation) 
and therefore may have a metabolic function. The possible 
physiological role in Drosophila of the different insulin and 
EGF-related growth factors that bind dpl00 is an intriguing 
question that remains to be answered. 
We  would  like  to thank  the  following people  for  generously  providing 
ligands: Drs. Michael Czech (University of Massachusetts  Medical Center, 
Worcester,  MA),  James  Tam  (Rockefeller  University,  New  York),  Joan 
Massague (University of Massachusetts  Medical Center),  Paul Pilch (Bos- 
ton University Medical School, Boston, MA), Gary Johnson (University of 
Massachusetts  Medical Center),  Joe Votano, Harry Antoniades (Harvard 
University School of Public  Health,  Boston, MA), Rik Derynck (Genen- 
tech,  San Francisco,  CA), and Francesco Blasi (International  Institute of 
Genetics and Biophysics, Naples, Italy). 
This work was supported by National  Cancer Institute Award CA35541 
(to M. R. Rosner),  Whitaker Health Sciences Fund Award (to M. R. Ros- 
ner),  National  Institute of Health Toxicology Training Grant T32-ES07020 
(to K. L. Thompson), and National Cancer  Institute Award CA37754  (to 
S. J.  Decker). 
Received for publication  3 November  1986, and in revised  form 16 March 
1987. 
References 
1. Bradford, M. M. 1976. A rapid and sensitive method for the quantification 
of microgram quantities of protein utilizing the principle of protein-dye 
binding. Anal  Biochem.  72:248-254. 
2. Decker,  S.  1984.  Purification  of denatured  epidermal  growth  factor- 
receptor from A43 i human epidermoid carcinoma cells. Arch. Biochem. 
Biophys.  228:621-626. 
3. Derynck, R., J. A. Jarrett, Y. E. Chen, D. H. Eaton, J. R. Bell, R. K. As- 
soian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel.  1985.  Human 
transforming growth factor-beta complementary DNA sequence and ex- 
pression in normal and transformed cells. Nature (Lond.).  316:701-705. 
4. Doolittle,  R. F., M. W. Hunkapiller, L. E. Hood, S. G. Devare, K. C. Rob- 
bins, S. A. Aaronson, and H. N. Antoniades. 1983. Simian sarcoma virus 
one gene, v-sis, is derived from the gene (or genes) encoding a platelet- 
derived growth factor.  Science (Wash.  DC). 221:275-277. 
5. Freychet, P., J. Roth, and D. M. Neville, Jr. 1971. Insulin receptors in the 
liver: specific binding of t2~I-insulin to the plasma membrane and its re- 
lation to insulin bioactivity.  Proc. Natl. Acad. Sci.  USA. 68:1833-1837. 
6. Friedman, B., A. R. Frackelton, A. H. Ross, H. Fujiki, R. Sugimura, and 
M.  R.  Rosner.  1984.  Tumor promoters block tyrosine-speciflc phos- 
phorylation of the epidermal growth factor receptor. Proc. Natl. Acad. 
Sci.  USA.  81:3034-3039. 
7. Gelbart, W. M., V. F. Irish, R. D. St. Johnston, F. M. Hoffman, R. Black- 
man, D. Segal, L. M. Posakony, and R. Grimaila.  1985. The decapen- 
taplegic  gene complex in Drosophila melanogaster. CoM Spring Harbor 
Syrup.  Quant.  Biol.  50:119-125. 
8. Greenwald, I.  1985. lin-12 a nematode homeotic gene is homologous to a 
set of mammalian proteins that includes epidermal growth factor.  Cell. 
43:583-590. 
9. Hollenberg, M. D., editor. 1985. Insulin: its Receptor and Diabetes. Mar- 
cel Dekker, Inc., NY. 
10. Houslay, M. D.  1985.  The insulin receptor and signal generation at the 
plasma membrane, P. Cohen, and M. D. Houslay, editors. In Molecular 
Aspects of Cellular Recognition, Vol.  4.  Elsevier:  NY, 279-334. 
11. Kidd, S., M. R. Kelley, and M. W. Young. 1986.  Sequence of the notch 
locus of Drosophila melanogaster:  relationship of the encoded protein to 
mammalian clotting and growth factors. Mol.  Cell. Biol.  6:3094-3108. 
12. LeRoith, D., M. A. Lesniak, and J. Roth. 1981. Insulin in insects and an- 
nelids. Diabetes.  30:70-76. 
13. Livneh, E., L. Glazer, D. Segal, J. Schlessinger, and B. Shilo.  1985. The 
Drosophila EGF receptor gene homolog: conservation of both hormone 
binding and kinase domains. Cell.  40:599-607. 
14. Marquardt, H., M. W. Hunkapiller, L. E. Hood, D. R. Twardzik, G. E. 
DeLarco, J.  R.  Stephenson, and G.  J.  Todaro.  1983.  Transforming 
growth factors produced by retrovirus-transformed rodent fibroblasts and 
human melanoma cells: amino acid sequence homology with epidermal 
growth factor.  Proc. Natl. Acad.  Sci.  USA.  80:4684-4688. 
15. Meneses, P., and M. D. L. A. Ortiz. 1975. A protein extract fromDrosoph- 
ila  melanogaster with insulin-like activity.  Comp.  Biochem.  Physiol. 
51A:483--485. 
16. O'Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of 
proteins. J.  Biol.  Chem.  250:4007--4021. 
17. Petruzzelli, L., R. Herrera, R. Garcia, and O. M. Rosen. 1985. The insulin 
receptor of Drosophila melanogaster.  In Growth Factors and Transfor- 
mation: Cancer Cells. Vol. 3. J. Feramisco, B. Ozanne, and C. Stiles, 
editors.  Cold  Spring  Harbor  Laboratory,  Cold  Spring  Harbor,  NY. 
115-121. 
18. Petruzzelli, L., R. Herrera, R. Garcia-Arenas, and O. M. Rosen. 1985. Ac- 
quisition of  insulin-dependent  protein tyrosine kinase activity during Dro- 
sophila embryogenesis. J.  Biol.  Chem.  260:16072-16075. 
19. Reisner, A. H. 1985. Similarity between the vaccinia virus 19K early pro- 
tein and epidermal growth factor.  Nature (Lond.).  313:801-803. 
20. Sato, G., and R. Ross. 1979. Hormones and Cell Culture. Cold Spring Har- 
bor Conf.  Cell Proliferation.  6. 
21. Schejter, E. D., D. Segal, L. Glaser, and B. Z. Shilo.  1986.  Alternative 
5' exons and tissue-specific expression of the Drosophila EGF receptor 
homolog transcripts. Cell.  46:1091-1101. 
22. Staros, J. V., S. Cohen, and M. W. Russo. 1985. Epidermal growth factor: 
characterization of its protein kinase activity. In Molecular Aspects of 
Cellular Recognition. P. Cohen and M.  D. Houslay, editors. Elsevier 
Science Publishing Co., Inc., New York.  153-277. 
23. Stoppelli,  M. P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R. As- 
soian. 1985. Differentiation  enhanced  binding of the amino-terminal frag- 
ment of human urokinase plasminogen activator to a specific receptor on 
U937 monocytes. Proc. Natl. Acad.  Sci.  USA.  82:4939--4943. 
24. Thompson, K. L., S. J. Decker, and M. R. Rosner.  1985.  Identification 
of a novel receptor in Drosophila for both epidermal growth factor and 
insulin. Proc. Natl. Acad.  Sci.  USA.  82:8443-8447. 
25. Ullrich, A., L. Coussens, J. S. Hayflick,  T. J. Dull, A. Gray, A. Tam, W. 
Lee, Y. Yarden, T. A. Liberman, J. Schlessinger, J. Downward,  E. L. V. 
Mayes, N. Whittle, M. D. Waterfield, and P. H. Seeburg. 1984. Human 
epidermal growth factor receptor eDNA sequence and aberrant expres- 
sion of the amplified gene in A431 epidermal carcinoma cells. Nature 
(Lond.).  309:418-425. 
26. Wharton, K. A., K. M. Johansen, T. Xu, and S. Artavanis-Tsakonas. 1985. 
Nucleotide sequence from the neurogenic locus notch implies a  gene 
product that shares homology with proteins containing EGF-like repeats. 
Cell.  43:567-581. 
27. Waterfield, M. D., G. T. Scrace, N. Whittle, P. Stroobant,  A. Johnsson, 
A. Wasteson, B. Westermark, C. H. Heldin, J.  S. Huang, and T. F. 
Deuel. 1983. Platelet-derived growth factor is structurally related to the 
putative transforming protein p28  s~ of simian sarcoma virus. Nature 
(Lond.).  304:35-39. 
28. Yarden, Y., J. A. Escobedo, W.-J. Kuang, T. L. Yang-Feng, T. O. Daniel, 
P. M. Tremble, E. Y. Chen, M. E. Ando, R. N. Harkins, U. Francke, 
V. A. Fried, A. Ullrieh, and L. T. Williams. 1986. Structure of  the recep- 
tor for platelet-derived  growth factor helps define a  family of closely 
related growth factor receptors. Nature (Lond.).  323:226-232. 
The Journal of Cell Biology, Volume 105,  1987  456 